Staphylococcal enterotoxin (SE) B causes serious gastrointestinal illness, and intoxication with this exotoxin can lead to lethal toxic shock syndrome. In order to overcome significant shortcomings of current rodent and nonhuman primate models, we developed a piglet model of lethal SEB intoxication. Fourteen-day-old Yorkshire piglets were given intravenous SEB, observed clinically, and sacrificed at 4, 6, 24, 48, 72, or 96 hrs posttreatment. Clinical signs were biphasic with pyrexia, vomiting, and diarrhea within 4 hrs, followed by terminal hypotension and shock by 96 hrs. Mild lymphoid lesions were identified as early as 24 hrs, with severe lymphadenopathy, splenomegaly, and prominent Peyer's patches found by 72 hrs. Widespread edema—most prominent in the mesentery, between loops of spiral colon, and in retroperitoneal connective tissue—was found in animals at 72 hrs. Additional histologic changes included perivascular aggregates of large lymphocytes variably present in the lung and brain, circulating lymphoblasts, and lymphocytic portal hepatitis. Preliminary molecular investigation using gene array has uncovered several gene profile changes that may have implications in the pathophysiology leading to irreversible shock. Five genes were selected for further study, and all showed increased mRNA levels subsequent to SEB exposure. The use of this piglet model will continue to elucidate the pathogenesis of SEB intoxication and facilitate the testing of new therapeutic regimens that may better correlate with human lesions.
JettM, BrinkleyW, NeillR, GemskiP, HuntR. Staphylococcus aureus enterotoxin B challenge of monkeys: correlation of plasma levels of arachidonic acid cascade products with occurrence of illness. Infect Immun58: 34943499, 1990.
2.
JarraudS, PeyratMA, LimA, TristanA, BesM, MougelC, EtienneJ, VandeneschF, BonnevilleM, LinaG. egc, a highly prevalent operon of enterotoxin gene, forms a putative nursery of superantigens in Staphylococcus aureus. J Immunol166: 669677, 2001.
3.
MarrackP, KapplerJ. The staphylococcal enterotoxins and their relatives [erratum, Science 248: 1066, 1990]. Science248: 705711, 1990.
4.
MiethkeT, WahlC, HeegK, EchtenacherB, KrammerP, WagnerH. T-cell–mediated lethal shock triggered in mice by the superantigen staphylococcal enterotoxin B: critical role of tumor necrosis factor. J Exp Med175: 9198, 1992.
5.
JohnsonHM, TorresBA, SoosJM. Superantigens: structure and relevance to human disease. Proc Soc Exp Biol Med212: 99109, 1996.
6.
JardetzkyTS, BrownJH, GorgaJC, SternLJ, UrbanRG, ChiY1, StauffacherC, StromingerJL, WileyDC. Three-dimensional structure of a human class II histocompatibility molecule complexed with superantigen. Nature368: 711718, 1994.
ShuppJW, JettM, PontzerCH. Identification of a transcytosis epitope on staphylococcal enterotoxins. Infect Immun70: 21782186, 2002.
10.
McKayDM, SinghPK. Superantigen activation of immune cells evokes epithelial (T84) transport and barrier abnormalities via IFN-gamma and TNF alpha: inhibition of increased permeability, but not diminished secretory responses by TGF-beta2. J Immunol159: 23822390, 1997.
11.
ChatterjeeS, KhullarM, ShiWY. Digalactosylceramide is the receptor for staphylococcal enterotoxin-B in human kidney proximal tubular cells. Glycobiology5: 327333, 1995.
12.
ChatterjeeS, JettM. Glycosphingolipids: the putative receptor for Staphylococcus aureus enterotoxin-B in human kidney proximal tubular cells. Mol Cell Biochem113: 2531, 1992.
13.
NormannSJ. Renal fate of staphylococcal enterotoxin B. Lab Invest25: 126132, 1971.
14.
CampbellWN, FitzpatrickM, DingX, JettM, GemskiP, GoldblumSE. SEB is cytotoxic and alters EC barrier function through protein tyrosine phosphorylation in vitro.Am J Physiol273: L31L39, 1997.
15.
NormannSJ, JaegerRF, JohnseyRT. Pathology of experimental enterotoxemia. The in vivo localization of staphylococcal enterotoxin B. Lab Invest20: 1725, 1969.
16.
StilesJW, DennistonJC. Response of the rhesus monkey, Macaca mulatta, to continuously infused staphylococcal enterotoxin B. Lab Invest25: 617625, 1971.
17.
UlrichRG, SidellS, TaylorTJ, WilhelmsenCL, FranzDR. Staphylococcal enterotoxin B and related pyrogenic toxins. In: SidellFR, TakafujiET, FranzDR, Eds. Textbook of Military Medicine. Part I: Warfare, Weaponry, and the Casualty. Medical Aspects of Chemical and Biological Warfare. Washington, DC: Office of the Surgeon General, pp 621630, 1997.
18.
SavranskyV, RostapshovV, PinelisD, PolotskyY, KorolevS, KomisarJ, FegedingK. Murine lethal toxic shock caused by intranasal administration of staphylococcal enterotoxin B. Toxicol Pathol31: 373378, 2003.
19.
AndersonMR, Tary-LehmannM. Staphylococcal enterotoxin-B-induced lethal shock in mice is T-cell–dependent, but disease susceptibility is defined by the non–T-cell compartment. Clin Immunol98: 8594, 2001.
20.
YeungRS, PenningerJM, KundigT, KhooW, OhashiPS, KroemerG, MakTW. Human CD4 and human major histocompatibility complex class II (DQ6) transgenic mice: supersensitivity to superantigen-induced septic shock. Eur J Immunol26: 10741082, 1996.
21.
ChenJY, QiaoY, KomisarJL, BazeWB, HsuIC, TsengJ. Increased susceptibility to staphylococcal enterotoxin B intoxication in mice primed with actinomycin D. Infect Immun62: 46264631, 1994.
22.
SchantzEJ, RoesslerWG, WagmanJ, SperoL, DunneryDA, BergdollMS. Purification of staphylococcal enterotoxin B. Biochemistry4: 10111016, 1965.
23.
FeletouM, TeisseireB. Vascular pharmacology of the micropig: importance of the endothelium. In: SwindleMM, MoodyDC, PhillipsLD, Eds. Swine As Models in Biomedical Research. Ames: Iowa State University Press, pp 7495, 1992.
HobanLD, PaschallJA, EcksteinJ, NadkariV, LeeCR, WilliamsTJ, ReuschD, NevolaJJ, CarcilloJA. Awake porcine model of intraperitoneal sepsis. In: SwindleMM, MoodyDC, PhillipsLD, Eds. Swine As Models in Biomedical Research. Ames: Iowa State University Press, pp 246264, 1992.
26.
FinegoldMJ. Interstitial pulmonary edema. An electron microscopic study of the pathology of staphylococcal enterotoxemia in Rhesus monkeys. Lab Invest16: 912924, 1967.
27.
LarkinSM, WilliamsDN, OsterholmMT, TofteRW, PosalakyZ. Toxic shock syndrome: clinical, laboratory, and pathologic findings in nine fatal cases. Ann Intern Med96: 858864, 1982.
28.
GelbergHB. Alimentary system. In: McGavinMD, CarltomWW, ZacharyJF, Eds. Thomson's Special Veterinary Pathology (3rd ed.). St. Louis: Mosby, pp 4243, 2001.
29.
PangVF, LorenzanaRM, BeasleyVR, BuckWB, HaschekWM. Experimental T-2 toxicosis in swine. III. Morphologic changes following intravascular administration of T-2 toxin. Fundam Appl Toxicol8: 298309, 1987.
30.
LandsverkT. Immune system. In: DellmannD, EurellJA, Eds. Textbook of Veterinary Histology (5th ed.). Baltimore: Williams & Wilkins, pp 137142, 1998.
HoffmanM, TremaineM, MansfieldJ, BetleyM. Biochemical and mutational analysis of the histidine residues of staphylococcal enterotoxin A. Infect Immun64: 885890, 1996.
33.
JinK, MaoXO, EshooMW, del RioG, RaoR, ChenD, SimonRP, GreenbergDA. cDNA microarray analysis of changes in gene expression induced by neuronal hypoxia in vitro. Neurochem Res27: 11051112, 2002.
34.
TenVS, PinskyDJ. Endothelial response to hypoxia: physiologic adaptation and pathologic dysfunction. Curr Opin Crit Care8: 242250, 2002.
35.
DroinNM, PinkoskiMJ, DejardinE, GreenDR. Egr family members regulate nonlymphoid expression of Fas ligand, TRAIL, and tumor necrosis factor during immune responses. Mol Cell Biol23: 76387647, 2003.
36.
HagiwaraH, SugiuraN, WakitaK, HiroseS. Purification and characterization of angiotensin-binding protein from porcine liver cytosolic fraction. Eur J Biochem185: 405410, 1989.
37.
WebbRC, KironMA, RosenbergE, SofferRL. Antiserum to angiotensin-binding protein inhibits vascular responses to angiotensin II. Am J Physiol255: H1542H1544, 1988.
